Acute and Chronic Allergic Conjunctivitis Treatment Market

Global Acute and Chronic Allergic Conjunctivitis Treatment Market Size, Share & Trends Analysis Report By Type (Acute and Chronic), and Forecast 2021-2027
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025250 | Category : Pharmaceuticals | Delivery Format: /

The global acute & chronic allergic conjunctivitis treatment market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Allergic conjunctivitis may be the result of eye trauma, contact lens wear, eye surgery, immune deficiency, or other diseases that as a result lead to the growth of bacteria. The allergy-related disorders have substantially grown owing to the high adoption of digital devices, and pollutants. Such factors have led to the surge in the demand for allergy relief eye drops as the primary form of treatment. Apart from all these factors, growth in the working population is also leading to several forms of eye-related allergies.

Besides, the number of acute and chronic allergic conjunctivitis cases is projected to rise globally in the near future. The major causes of the same include inadequate eye hygiene habits, an increasing number of post-operative eye infections, coupled with the emergence of new pathogens. As per the survey conducted by the National Ambulatory Medical Care Survey, in 2005, approximately 70% of patients with acute conjunctivitis consult primary and urgent care providers, accounting for 1.0% of overall primary care office visits. Further, adenoviruses account for 65-90% of cases of viral conjunctivitis. In addition, the global incidence of herpes simplex keratitis was calculated at approximately 1.5 million with 40,000 new cases of severe monocular visual impairment or blindness a year.

Some key players operating in the market include Novartis AG, Allergan, Bausch Health, and others. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape:  Akorn Inc., Allergan, Novartis International AG, Bausch Health, among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Acute and Chronic Allergic Conjunctivitis Treatment Market - Segmentation

By Type 

Acute Allergic Conjunctivitis

Chronic Allergic Conjunctivitis

Global Acute and Chronic Allergic Conjunctivitis Treatment Market Segmentation by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World